| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 778,710 | 968,220 | 544,786 | | Cost of Revenue | 638,343 | 808,447 | 464,782 | | | Gross Profit | 140,367 | 159,773 | 80,003 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 59,576 | 68,158 | 34,420 | | Non Recurring | 145,347 | 175 | 830 | | Others | 870 | 1,176 | 504 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (65,427) | 90,264 | 44,250 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,558) | (22,285) | 4,506 | | Earnings Before Interest And Taxes | (71,985) | 67,979 | 47,068 | | Interest Expense | 25,929 | 26,433 | 31,069 | | Income Before Tax | (97,914) | 41,546 | 16,000 | | Income Tax Expense | 11,816 | 116 | (1,419) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (109,730) | 41,430 | 19,105 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (109,730) | 41,430 | 19,105 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($109,730) | $41,430 | $19,105 |
|
1.23% Nasdaq 0.00%
Income Statement
